Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics

13Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Actinic keratosis (AK) is considered as superficial squamous cell carcinoma. Chronic sun exposure plays a central role in its pathogenesis. In particular, ultraviolet B radiation causes direct damage to the DNA, producing pyrimidine dimers that suppress the protective role of p53. Other risk factors include advanced age, male sex, and fair skin type. Even some drugs used for treating blood hypertension, such as thiazide diuretics, can increase the risk of developing AK. Their photosensitizing action seems to be connected with reactive oxygen species production. We report our experience with ten patients affected by multiple AK, in therapy with thiazide diuretics, treated by ingenol mebutate gel. AK was clinically and dermoscopically evaluated at baseline and after 30 days from the beginning of the treatment. Moreover, patients were screened for vitamin D3 values and reported a general hypovitaminosis status. To our knowledge, we report for the first time the efficacy of ingenol mebutate gel in this group of patients, particularly at risk of developing AK.

Cite

CITATION STYLE

APA

Campione, E., Di Prete, M., Diluvio, L., Bianchi, L., & Orlandi, A. (2016). Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics. Clinical, Cosmetic and Investigational Dermatology, 9, 405–409. https://doi.org/10.2147/CCID.S111305

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free